Evaluation of [18F]MC225-PET to Measure P-glycoprotein Function in Neurodegenerative Disease
Evaluation of [18F]MC225-PET to Measure P-glycoprotein Function in Neurodegenerative Disease is a PHASE1 clinical asset sponsored by University Medical Center Groningen in Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease, Mild Cognitive Impairment. SEO and diligence focus: [18F]MC225, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Neurodegenerative Diseases
Modality: small molecule
Target: [18F]MC225
Sponsor: University Medical Center Groningen
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 24, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: [18F]MC225
View original source fields
Condition raw: Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease, Mild Cognitive Impairment
Condition normalized: Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease, Mild Cognitive Impairment
Modality raw: small molecule
Modality normalized: small molecule
Target raw: [18F]MC225
Target normalized: [18F]MC225